Clinical Trials in Texas

Showing 3281-3300 of 12,973 trials

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

NCT06369220

This study is designed to assess the comparative clinical utility of the point of care cobas® liat CT/NG/MG to current standard practices in the diagnosis and treatment of urogenital infections with Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium (MG).

Chlamydia Trachomatis InfectionNeisseria Gonorrhoeae InfectionMycoplasma Genitalium Infection

Hoffmann-La Roche344 participantsStarted Jul 2024

San Francisco, California, United States • Hamilton Square, New Jersey, United States • Perth Amboy, New Jersey, United States +1 more locations

COMPLETEDPhase 255 miles

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

NCT05568706

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult subjects with confirmed RSV infection who are at high risk for complications after RSV infection.

RSV Infection

Enanta Pharmaceuticals, Inc186 participantsStarted Nov 2022

Tempe, Arizona, United States • Fresno, California, United States • Lomita, California, United States +81 more locations

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Find Trials by Condition in Texas

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

A Study of LY3541105 in Healthy and Overweight Participants

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device

Distal Radius Interventions for Fracture Treatment

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

Vaginal Ecosystem and Network in the United States Study

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

LTFU for All Cell and Gene Therapy Studies

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

Cough Reduction in IPF With Nalbuphine ER